Sun Kaibo, Wu Yuangang, Zeng Yi, Li Mingyang, Wu Limin, Shen Bin
Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 Jun 15;37(6):758-763. doi: 10.7507/1002-1892.202302056.
To review the research progress of mitochondrial dynamics mediated by optic atrophy 1 (OPA1) in skeletal system diseases.
The literatures about OPA1-mediated mitochondrial dynamics in recent years were reviewed, and the bioactive ingredients and drugs for the treatment of skeletal system diseases were summarized, which provided a new idea for the treatment of osteoarthritis.
OPA1 is a key factor involved in mitochondrial dynamics and energetics and in maintaining the stability of the mitochondrial genome. Accumulating evidence indicates that OPA1-mediated mitochondrial dynamics plays an important role in the regulation of skeletal system diseases such as osteoarthritis, osteoporosis, and osteosarcoma.
OPA1-mediated mitochondrial dynamics provides an important theoretical basis for the prevention and treatment of skeletal system diseases.
综述视神经萎缩蛋白1(OPA1)介导的线粒体动力学在骨骼系统疾病中的研究进展。
回顾近年来关于OPA1介导的线粒体动力学的文献,总结治疗骨骼系统疾病的生物活性成分和药物,为骨关节炎的治疗提供新思路。
OPA1是参与线粒体动力学和能量代谢以及维持线粒体基因组稳定性的关键因素。越来越多的证据表明,OPA1介导的线粒体动力学在骨关节炎、骨质疏松症和骨肉瘤等骨骼系统疾病的调控中发挥重要作用。
OPA1介导的线粒体动力学为骨骼系统疾病的防治提供了重要的理论依据。